- 2024-08-20 02:17抑制剂Verucerfont|Verucerfont|885220-61-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:17抑制剂VGX-1027|VGX-1027|6501-72-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:17抑制剂VEGFR-2-IN-5|VEGFR-2-IN-5|1430089-64-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:17抑制剂VEGFR-2-IN-5|VEGFR-2-IN-5|1430089-64-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:17抑制剂VBIT-12|VBIT-12|2089227-65-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:17抑制剂VB124|VB124|2230186-18-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:17抑制剂VB124|VB124|2230186-18-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:17抑制剂VBIT-12|VBIT-12|2089227-65-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:17抑制剂VB124|VB124|2230186-18-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:17抑制剂Vazegepant hydrochloride|Vazegepant hydrochloride|1414976-20-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:17抑制剂Vazegepant hydrochloride|Vazegepant hydrochloride|1414976-20-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂Vazegepant hydrochloride|Vazegepant hydrochloride|1414976-20-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:16抑制剂V-9302|V-9302|1855871-76-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:16抑制剂V-9302|V-9302|1855871-76-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂V-9302|V-9302|1855871-76-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂Valemetostat|Valemetostat|1809336-39-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂UNC2541|UNC2541|1612782-86-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂UNC926 hydrochloride|UNC926 hydrochloride|1782573-49-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:16抑制剂UT-155|UT-155|2031161-35-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:16抑制剂UNC1079|UNC1079|1418741-86-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
